SOTAC PHARMACEUTICALS
Back to Balance Sheet
|
SOTAC PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹123 Cr | ₹104 Cr | ₹74 Cr | ₹35 Cr | ₹35 Cr |
What is the latest Total Liabilities ratio of SOTAC PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹123 Cr |
| Mar2024 | ₹104 Cr |
| Mar2023 | ₹74 Cr |
| Mar2022 | ₹35 Cr |
| Mar2021 | ₹35 Cr |
How is Total Liabilities of SOTAC PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹123 Cr | 18.41 | |
| Mar2024 | ₹104 Cr | 41.09 | |
| Mar2023 | ₹74 Cr | 109.01 | |
| Mar2022 | ₹35 Cr | 1.54 | |
| Mar2021 | ₹35 Cr | - | |
Compare Total Liabilities of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹100.0 Cr | -5.3% | -15.1% | -25.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,180.0 Cr | 1.6% | -1% | 22.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,302.0 Cr | 1.7% | 10.1% | 49.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,623.0 Cr | 1.5% | -1.2% | 38.2% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | 0.7% | -3.5% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,741.0 Cr | -1.3% | 0.1% | -7.8% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -5.3% |
-15.1% |
-25.9% |
| SENSEX | -0.9% |
-1.5% |
-5.8% |
You may also like the below Video Courses